Artículos de revistas sobre el tema "Biopsy-based transcriptomics"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Biopsy-based transcriptomics".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Ungar, B., M. Yavzori, E. Fudim, O. Picard, U. Kopylov, R. Eliakim, D. Shouval et al. "P032 Host transcriptome signatures in human fecal-washes predict histological remission in IBD patients". Journal of Crohn's and Colitis 16, Supplement_1 (1 de enero de 2022): i152—i153. http://dx.doi.org/10.1093/ecco-jcc/jjab232.161.
Texto completoDan, S., B. Ungar, S. Ben-Moshe, K. Bahar Halpern, M. Yavzori, E. Fudim, O. Picard et al. "P017 Fecal wash host transcriptomics identifies inflammation throughout the colon and terminal ileum". Journal of Crohn's and Colitis 17, Supplement_1 (30 de enero de 2023): i188. http://dx.doi.org/10.1093/ecco-jcc/jjac190.0147.
Texto completoVoutetakis, Konstantinos, Aristotelis Chatziioannou, Efstathios S. Gonos y Ioannis P. Trougakos. "Comparative Meta-Analysis of Transcriptomics Data during Cellular Senescence andIn VivoTissue Ageing". Oxidative Medicine and Cellular Longevity 2015 (2015): 1–17. http://dx.doi.org/10.1155/2015/732914.
Texto completoDinis Fernandes, Catarina, Annekoos Schaap, Joan Kant, Petra van Houdt, Hessel Wijkstra, Elise Bekers, Simon Linder et al. "Radiogenomics Analysis Linking Multiparametric MRI and Transcriptomics in Prostate Cancer". Cancers 15, n.º 12 (6 de junio de 2023): 3074. http://dx.doi.org/10.3390/cancers15123074.
Texto completoCherry, Hannah, Joe Rastrick, Joanna Jacków, Maddy Parsons y John McGrath. "O22 Unravelling the pathophysiology of KLICK syndrome to identify therapeutically targetable pathways". British Journal of Dermatology 190, n.º 6 (17 de mayo de 2024): e78-e79. http://dx.doi.org/10.1093/bjd/ljae105.022.
Texto completoBoldanova, Tuyana, Geoffrey Fucile, Jan Vosshenrich, Aleksei Suslov, Caner Ercan, Mairene Coto-Llerena, Luigi M. Terracciano et al. "Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization". Cell Reports Medicine 2, n.º 11 (noviembre de 2021): 100444. http://dx.doi.org/10.1016/j.xcrm.2021.100444.
Texto completoZhang, Yueyun, Carlos Henrique Venturi Ronchi, Giovanna Ambrosini, Yuanlong Liu, Patrick Aouad, Daria Matvienko, Christoph Merten y Cathrin Brisken. "Abstract PO5-14-06: Transcriptomics-based drug screening in 3D ex vivo patient-drived breast cancer model and patient biopsy for personalized therapy". Cancer Research 84, n.º 9_Supplement (2 de mayo de 2024): PO5–14–06—PO5–14–06. http://dx.doi.org/10.1158/1538-7445.sabcs23-po5-14-06.
Texto completoCimadamore, Alessia, Silvia Gasparrini, Francesco Massari, Matteo Santoni, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli y Rodolfo Montironi. "Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy". Cancers 11, n.º 2 (7 de febrero de 2019): 196. http://dx.doi.org/10.3390/cancers11020196.
Texto completoDas, Sreyashi, Mohan Kumar Dey, Ram Devireddy y Manas Ranjan Gartia. "Biomarkers in Cancer Detection, Diagnosis, and Prognosis". Sensors 24, n.º 1 (20 de diciembre de 2023): 37. http://dx.doi.org/10.3390/s24010037.
Texto completovan Bergen, Cornelis A. M., Marvyn T. Koning, Edwin Quinten, Agnieszka Mykowiecka, Julieta Sepulveda, Ramin Monajemi, Ruben A. L. De Groen et al. "High-Throughput BCR Sequencing and Single-Cell Transcriptomics Reveal Distinct Transcriptional Profiles Associated with Subclonal Evolution of Follicular Lymphoma". Blood 134, Supplement_1 (13 de noviembre de 2019): 298. http://dx.doi.org/10.1182/blood-2019-130508.
Texto completoKersch, Cymon, Cheryl Claunch, Prakash Ambady, Elmar Bucher, Daniel Schwartz, Ramon Barajas, Jeffrey Iliff, Laura Heiser, Leslie Muldoon y Edward Neuwelt. "PATH-63. TRANSCRIPTIONAL SIGNATURES IN HISTOLOGIC STRUCTURES WITHIN GLIOBLASTOMA TUMORS MAY PREDICT PERSONALIZED TREATMENT SENSITIVITY AND SURVIVAL". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi157. http://dx.doi.org/10.1093/neuonc/noz175.658.
Texto completoLee, Irene Tai-Lin, Chin-Hsuan Shen, Feng-Chiao Tsai, Chun-Bing Chen y Kevin Sheng-Kai Ma. "Cancer-Derived Extracellular Vesicles as Biomarkers for Cutaneous Squamous Cell Carcinoma: A Systematic Review". Cancers 14, n.º 20 (18 de octubre de 2022): 5098. http://dx.doi.org/10.3390/cancers14205098.
Texto completoKretschmer-Kazemi Far, Rosel, Kirsten Frank y Georg Sczakiel. "Sampling, Logistics, and Analytics of Urine for RT-qPCR-based Diagnostics". Cancers 13, n.º 17 (30 de agosto de 2021): 4381. http://dx.doi.org/10.3390/cancers13174381.
Texto completoCook, Daniel, Dorys Lopez, Anu K. Antony, The SimBioSys Team y John A. Cole. "Multimodal approach to capture spatially resolved single-cell tumor heterogeneity in breast cancer." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): e12597-e12597. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e12597.
Texto completoCook, Daniel, Dorys Lopez, Anu K. Antony, The SimBioSys Team y John A. Cole. "Multimodal approach to capture spatially resolved single-cell tumor heterogeneity in breast cancer." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): e12597-e12597. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e12597.
Texto completoGjyrezi, Ada, Charalampos Skarlis, Paul Zumbo, Doron Betel, Ioanna E. Stergiou, Michael Voulgarelis, Clio P. Mavragani y Paraskevi Giannakakou. "Abstract 1404: Blood-based transcriptomics provides novel insights into Sjögren's syndrome-associated lymphomagenesis". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 1404. http://dx.doi.org/10.1158/1538-7445.am2024-1404.
Texto completoYohihara, R., H. Tsuchiya, Y. Omata, H. Takahashi, S. Nakajima, H. Mizuhara, A. Uchio et al. "POS1014 INVESTIGATING THE SYNOVIAL PATHOLOGY RELATED TO TREATMENT RESISTANCE IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS USING SINGLE-CELL ANALYSIS". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 823.1–823. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1112.
Texto completoOrsini, Arianna, Chiara Diquigiovanni y Elena Bonora. "Omics Technologies Improving Breast Cancer Research and Diagnostics". International Journal of Molecular Sciences 24, n.º 16 (11 de agosto de 2023): 12690. http://dx.doi.org/10.3390/ijms241612690.
Texto completoMiller, Dulaney, Kyle Manning, Shuran Xing, T. Jeffrey Cole, Christopher J. Benway, Elena M. Cortizas, J. Christian J. Ray et al. "Stratification of patients with prostate cancer using a comprehensive multiomic approach: Integrating extracellular vesicle transcriptomics profiling with cfDNA methylation in urine-based liquid biopsy." Journal of Clinical Oncology 42, n.º 16_suppl (1 de junio de 2024): e17095-e17095. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e17095.
Texto completoQuek, Camelia, Aditya Pratapa, Ines Pires da Silva, Ghamdan Al-Eryani, Aaron Mayer, Nenad Bartonicek, Kate Harvey et al. "Abstract 4621: Distinct spatial and molecular maps in the tumour microenvironment of resistant melanoma patients treated with checkpoint inhibitor immunotherapy". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 4621. http://dx.doi.org/10.1158/1538-7445.am2023-4621.
Texto completoFRENEL, Jean Sebastien, Fadoua Ben Azzouz, Frederic Bigot, Jonathan Dauve, Marie Francoise Heymann, Wilfried Gouraud, Catherine Guette et al. "Abstract P5-02-37: Multi-omics approach to identify markers of resistance to endocrine therapy + CDK4/6 inhibitors in first line HR+/HER2- metastatic breast cancer (MBC) patients". Cancer Research 83, n.º 5_Supplement (1 de marzo de 2023): P5–02–37—P5–02–37. http://dx.doi.org/10.1158/1538-7445.sabcs22-p5-02-37.
Texto completoNeagu, Anca-Narcisa, Danielle Whitham, Pathea Bruno, Hailey Morrissiey, Celeste A. Darie y Costel C. Darie. "Omics-Based Investigations of Breast Cancer". Molecules 28, n.º 12 (14 de junio de 2023): 4768. http://dx.doi.org/10.3390/molecules28124768.
Texto completoChang, Ming-Ling y Sien-Sing Yang. "Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology". Cells 8, n.º 11 (12 de noviembre de 2019): 1423. http://dx.doi.org/10.3390/cells8111423.
Texto completoDu, Mulong. "Prospective of Mitochondrial DNA Variations in Cancer on Genomic Medicine". Cancer Epidemiology, Biomarkers & Prevention 33, n.º 6 (3 de junio de 2024): 766–68. http://dx.doi.org/10.1158/1055-9965.epi-24-0233.
Texto completoReis Nisa, P. I., C. Mahony, C. Smith, C. D. Buckley, K. Raza, A. Filer, D. Windell, M. Coles y A. Croft. "OP0094 SPATIAL POSITIONING AND MATRIX PROGRAMS OF SYNOVIAL FIBROBLASTS UNDERPIN IMMUNE CELL ORGANISATION AND SYNOVIAL TISSUE PATHOTYPE". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 64.2–64. http://dx.doi.org/10.1136/annrheumdis-2023-eular.6114.
Texto completoLin, Pei-Hsuan, Wan-Ping Su, Chia-Jung Li, Li-Te Lin, Jim Jinn-Chyuan Sheu, Zhi-Hong Wen, Jiin-Tsuey Cheng y Kuan-Hao Tsui. "Investigating the Role of Ferroptosis-Related Genes in Ovarian Aging and the Potential for Nutritional Intervention". Nutrients 15, n.º 11 (25 de mayo de 2023): 2461. http://dx.doi.org/10.3390/nu15112461.
Texto completoSitnikova, Suzanne Isabelle, Sophie Munnings-Tomes, Elena Galvani, Stacy Kentner, Kathy Mulgrew, Chris Rands, Judit España Agustí et al. "Novel non-terminal tumor sampling procedure using fine needle aspiration supports immuno-oncology biomarker discovery in preclinical mouse models". Journal for ImmunoTherapy of Cancer 9, n.º 6 (junio de 2021): e002894. http://dx.doi.org/10.1136/jitc-2021-002894.
Texto completoImai, Mitsuho, Jinyeong Lim, Naoko Iida, Hiromichi Ebi, Wataru Okamoto, Takeshi Kato, Taito Esaki et al. "Deciphering tumor microenvironment dynamics in HER2-amplified refractory metastatic colorectal cancer in the TRIUMPH trial." Journal of Clinical Oncology 42, n.º 16_suppl (1 de junio de 2024): 3564. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3564.
Texto completoNaing, Aung, Hirva Mamdani, Minal A. Barve, Melissa Lynne Johnson, Sam Darko, Julie A. Murphy, Lauren Trogun et al. "Investigation of a potential protein biomarker signature that may predict clinical benefit of NT-I7 and pembrolizumab in patients with cold gastrointestinal tumors." Journal of Clinical Oncology 42, n.º 16_suppl (1 de junio de 2024): 2563. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.2563.
Texto completoTesfaye, D., N. Ghanem, F. Rings, E. Tholen, C. Phatsara, K. Schellander y M. Hoelker. "196 EMBRYO BIOPSY TRANSCRIPTOMICS: A POTENTIAL TOOL TO IDENTIFY TRANSCRIPTS DIRECTLY RELATED TO THE ABILITY OF THE EMBRYO TO INDUCE PREGNANCY AFTER TRANSFER". Reproduction, Fertility and Development 21, n.º 1 (2009): 196. http://dx.doi.org/10.1071/rdv21n1ab196.
Texto completoBojmar, Linda, Constantinos P. Zambirinis, Jonathan Hernandez, Jayasree Chakraborty, Samer Hanna, Diane Simeone, David Kelsen et al. "Abstract PR012: Perioperative liver biopsy captures features of the liver pre-metastatic niche and predicts metastatic outcome after pancreatic cancer resection". Cancer Research 82, n.º 22_Supplement (15 de noviembre de 2022): PR012. http://dx.doi.org/10.1158/1538-7445.panca22-pr012.
Texto completoTreaba, Diana O., Dennis M. Bonal, Anna D. Chorzalska, Christoph Schorl, Kelsey Hopkins, John L. Reagan, Peter Rintels, Peter J. Quesenberry y Patrycja M. Dubielecka. "Levels of Osteopontin (SPP1), Osteonectin (SPARC) and Biglycan (BGN) in Acute Myeloid Leukemia Bone Marrow Biopsies Post-Induction Therapy Define the Status of Osteogenic Niche and Show Inverse Correlation with Therapeutic Response". Blood 136, Supplement 1 (5 de noviembre de 2020): 29–30. http://dx.doi.org/10.1182/blood-2020-142604.
Texto completoNikfar, Mehdi, Haoyang Mi, Chang Gong, Holly Kimko y Aleksander S. Popel. "Quantifying Intratumoral Heterogeneity and Immunoarchitecture Generated In-Silico by a Spatial Quantitative Systems Pharmacology Model". Cancers 15, n.º 10 (13 de mayo de 2023): 2750. http://dx.doi.org/10.3390/cancers15102750.
Texto completoClemenceau, Jean R., Paola Suarez Meade, Mark E. Jentoft, Alfredo Quiñones-Hinojosa y Tae Hyun Hwang. "Abstract 144: Spatial transcriptomic landscape of the primary and recurrent glioblastoma tumor microenvironment". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 144. http://dx.doi.org/10.1158/1538-7445.am2023-144.
Texto completoAnderson, Chiron J. y Stephan Schmitz-Esser. "41 Differential Gene Expression of the Bovine Rumen Epithelial Microbiota During a Sub-acute Ruminal Acidosis (SARA) Challenge". Journal of Animal Science 100, Supplement_2 (12 de abril de 2022): 12. http://dx.doi.org/10.1093/jas/skac064.018.
Texto completoLopez-Escalera, Silvia, Mari L. Lund, Gerben D. A. Hermes, Béatrice S. Y. Choi, Kei Sakamoto y Anja Wellejus. "In Vitro Screening for Probiotic Properties of Lactobacillus and Bifidobacterium Strains in Assays Relevant for Non-Alcoholic Fatty Liver Disease Prevention". Nutrients 15, n.º 10 (18 de mayo de 2023): 2361. http://dx.doi.org/10.3390/nu15102361.
Texto completoKugler, M., M. Dellinger, F. Kartnig, L. Müller, T. Preglej, L. Heinz, E. Simader et al. "AB0056 CYTOKINE-DIRECTED CELLULAR CROSSTALK IMPRINTS SYNOVIAL PATHOTYPES IN RHEUMATOID ARTHRITIS". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 1207.2–1207. http://dx.doi.org/10.1136/annrheumdis-2023-eular.6440.
Texto completoRing, Alexander, Daniel Campo, Tania B. Porras, Pushpinder Kaur, Victoria A. Forte, Debu Tripathy, Janice Lu et al. "Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer". Annals of Surgical Oncology 29, n.º 5 (9 de enero de 2022): 2882–94. http://dx.doi.org/10.1245/s10434-021-11135-2.
Texto completoChen, L., C. Zhang, R. Niu, R. Mao, Y. Qiu y R. Feng. "P915 Multi-Omics Biomarkers for the Prediction of Response to Biologics in Patients with Inflammatory Bowel Disease". Journal of Crohn's and Colitis 18, Supplement_1 (1 de enero de 2024): i1670—i1671. http://dx.doi.org/10.1093/ecco-jcc/jjad212.1045.
Texto completoPatil, Madhuri. "What is the Optimum Endometrium Needed for Implantation?" Fertility & Reproduction 05, n.º 04 (diciembre de 2023): 290. http://dx.doi.org/10.1142/s2661318223741048.
Texto completoYu, Liping. "Abstract 1393: A Novel platform providing automated, consistent and gentle cell isolation from tissues for downstream applications". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 1393. http://dx.doi.org/10.1158/1538-7445.am2022-1393.
Texto completoBahrambeigi, Vahid, Jaewon J. Lee, Kimal I. Rajapakshe, Bret M. Stephens, Jason T. Henry, Sarah Dhebat, Mark W. Hurd et al. "Abstract PR013: Transcriptomic profiling of liquid biopsy in colorectal cancer". Cancer Research 82, n.º 23_Supplement_1 (1 de diciembre de 2022): PR013. http://dx.doi.org/10.1158/1538-7445.crc22-pr013.
Texto completoIwamoto, F., O. Al Dalahmah, K. Manjrekar, C. Levrero, R. Michel, A. Bargo, S. Kaesshaefer et al. "P11.82.A TARGETING THE GLIOBLASTOMA MASTER REGULATOR C/EBPß: A PHARMACOKINETIC AND PHARMACODYNAMIC NEOADJUVANT STUDY OF ST101". Neuro-Oncology 25, Supplement_2 (1 de septiembre de 2023): ii95. http://dx.doi.org/10.1093/neuonc/noad137.316.
Texto completoHasanov, Elshad, Lesley Flynt, Rebecca Tidwell, Hyunsoo Hwang, Roserika Brooks, Lauren Michelle Wood, Travis Solley et al. "Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naive patients with advanced clear cell RCC." Journal of Clinical Oncology 42, n.º 4_suppl (1 de febrero de 2024): TPS496. http://dx.doi.org/10.1200/jco.2024.42.4_suppl.tps496.
Texto completoJonasch, Eric, Elshad Hasanov, Lesley Flynt, Hyunsoo Hwang, Rebecca Slack Tidwell, Roserika Brooks, Lauren Michelle Wood et al. "Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naive patients with advanced clear cell RCC." Journal of Clinical Oncology 42, n.º 16_suppl (1 de junio de 2024): TPS4610. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.tps4610.
Texto completoCampbell, Katie M., Zaid Bustami, Daniel G. Chen, Egmidio Medina, Cynthia R. Gonzalez, Nataly Naser Aldeen, Ignacio Baselga-Carretero et al. "Abstract 6550: Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1 refractory melanoma". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 6550. http://dx.doi.org/10.1158/1538-7445.am2024-6550.
Texto completoGenta, Sofia, Ming Sound Tsao, Ben X. Wang, Aaron Richard Hansen, Trevor John Pugh, Mathieu Lupien, Bryan Coburn et al. "Immune Resistance Interrogation Study (IRIS): A prospective comprehensive multi-omic analysis in patients with intrinsic and acquired resistance to immunotherapy." Journal of Clinical Oncology 39, n.º 15_suppl (20 de mayo de 2021): TPS2679. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.tps2679.
Texto completoHasanov, Elshad, Lesley Flynt, Rebecca Slack Tidwell, Hyunsoo Hwang, Roserika Brooks, Lauren Michelle Wood, Travis Solley et al. "Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junio de 2023): TPS4605. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.tps4605.
Texto completoHasanov, Elshad, Lesley Flynt, Rebecca Slack Tidwell, Hyunsoo Hwang, Roserika Brooks, Lauren Michelle King, Travis Solley et al. "Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC." Journal of Clinical Oncology 41, n.º 6_suppl (20 de febrero de 2023): TPS749. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.tps749.
Texto completoHasanov, Elshad, Lesley Flynt, Rebecca Slack Tidwell, Hyunsoo Hwang, Roserika Brooks, Lauren King, Travis Solley et al. "STARLITE 1: Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC". Oncologist 28, Supplement_1 (23 de agosto de 2023): S13. http://dx.doi.org/10.1093/oncolo/oyad216.021.
Texto completo